Company Description
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide.
It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products.
The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars.
In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime.
Further, it offers its products through direct sales and services, and network of distributors and direct international sales.
Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
| Country | United States |
| Founded | 1988 |
| IPO Date | Mar 31, 2004 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 430 |
| CEO | Taylor C. Harris |
Contact Details
Address: 3240 Bayshore Boulevard Brisbane, California 94005 United States | |
| Phone | 94005 |
| Website | cutera.com |
Stock Details
| Ticker Symbol | CUTR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001162461 |
| CUSIP Number | 232109108 |
| ISIN Number | US2321091082 |
| Employer ID | 77-0492262 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Taylor C. Harris | President, Chief Executive Officer and Director |
| Dr. Michael A. Karavitis Ph.D. | Executive Vice President and Chief Technology Officer |
| Stuart Drummond | Interim Chief Financial Officer |
| Jeffrey S. Jones | Chief Operating Officer |
| Charles G. Thier | Chief Information Officer |
| Anne Werdan | Director of Investor Relations |
| Dr. Stephana E. Patton J.D., Ph.D. | Chief Legal Officer |
| Steve Kreider | Senior Vice President of Global Marketing |
| Brent Hauser | President of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 18, 2024 | 8-K | Current Report |
| Jul 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 2, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 1, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jul 1, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 27, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 17, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 7, 2024 | 8-K | Current Report |
| Jun 7, 2024 | PRE 14A | Other preliminary proxy statements |
| Jun 3, 2024 | 8-K | Current Report |